论文部分内容阅读
作者关注着科兰损伤组白蛋白评述者的发现,他们提出使用人血白蛋白可以增大危重病病人的死亡率。在英国对于患脑膜炎双球菌病的儿童推荐使用的主要复苏液之一是白蛋白。作者发现这种应用流传广泛。 1992～1994年,作者研究了莫日赛德(Merseyside)四家医院收治的患有脑膜炎双球菌病的126名儿童。106名(84％)应用人血白蛋白,也括患有严重疾病的46名中的45名。这106名儿童中有9名皮肤核心温差小于3℃,表示他们没有休克。 作者之一(AW)1997年在伯明翰研究了疑为脑膜炎双球菌败血症的27名儿童的早期治疗。有25名儿童第一小时都用了输液。2名儿童用的是标准盐溶液,另外23名用的是4.5％白
The authors are concerned about the findings of the Glaucoma albumin review group who suggested that using human serum albumin may increase the mortality of critically ill patients. One of the major resuscitation solutions recommended for children suffering from meningococcal disease in the UK is albumin. The authors found this kind of application widespread. From 1992 to 1994, the authors studied 126 children with meningococcal disease who were admitted to four hospitals in Merseyside. 106 (84%) applied human albumin and 45 out of 46 patients with severe illness. Nine of the 106 children had a core temperature difference of less than 3 ° C, indicating that they had no shock. One of the authors (AW) studied the early treatment of 27 children suspected of meningococcal sepsis in Birmingham in 1997. Twenty-five children used infusion for the first hour. Two children used a standard salt solution and another 23 used 4.5% white